Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARTH: Alpha-1 Antitrypsin in Alcohol-Associated Hepatitis
NCT06582329Phase 2Recruiting
- Sponsor
- Medical University of Innsbruck
- Start
- Jun 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-1-proteinase inhibitor in alcoholic hepatitis (AH), sponsored by Medical University of Innsbruck. Started Jun 2025; status: recruiting.
02
Drugs
alpha-1-proteinase inhibitor
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT06582329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06582329.